Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetyltransferases and tumour suppression.

A C Phillips1, K H Vousden

  • 1Regulation of Cell Growth Laboratory, NCI-FCRDC, Frederick, Maryland 21702-1201, USA. phillips@ncifcrf.gov

Breast Cancer Research : BCR
|March 16, 2001
PubMed
Summary

The acetyltransferase p300 (also known as EP300) may function as a tumor suppressor. Recent research found mutations in p300 in human cancers, suggesting its loss contributes to tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular reactivity patterns and pathways to hypertension: a multivariate cluster analysis.

Journal of human hypertension·2016
Same author

p53- and p73-independent activation of TIGAR expression in vivo.

Cell death & disease·2015
Same author

Functional interplay between MDM2, p63/p73 and mutant p53.

Oncogene·2014
Same author

Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.

Cell death and differentiation·2014
Same author

Suppression of acetate mutants in Coprinus : I. Identification of two isoaccepting tRNA suppressors of a missense mutation.

Current genetics·2013
Same author

Suppression of acetate mutants in Coprinus : II. Correlation of recessiveness and dosage effects with suppressed enzyme level.

Current genetics·2013

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • The acetyltransferase p300 was initially identified in association with the adenoviral transforming protein E1A.
  • This association suggested a potential role for p300 in regulating cell proliferation.

Purpose of the Study:

  • To investigate the role of p300 in human tumors.
  • To provide direct evidence for p300's function in cancer development.

Main Methods:

  • Analysis of tumor samples and cell lines for mutations in the p300 gene.
  • Identification of truncating mutations and loss or mutation of the second allele.

Main Results:

  • Direct evidence supporting a tumor suppressor role for p300 in human cancers was established.
  • Truncating mutations and loss of heterozygosity in p300 were identified in tumor samples and cell lines.

Conclusions:

  • Loss or mutation of p300 is implicated in the development of a subset of human cancers.
  • p300 functions as a tumor suppressor, and its alteration contributes to oncogenesis.

Related Experiment Videos